scholarly article | Q13442814 |
P50 | author | Donald R Ronning | Q56929923 |
Steven J Sucheck | Q56929936 | ||
P2093 | author name string | Sri Kumar Veleti | |
Brittney N Wilson | |||
Jared J Lindenberger | |||
P2860 | cites work | Totally drug-resistant tuberculosis in India. | Q55055446 |
Five-membered ring azasugars as potent inhibitors of alpha-L-rhamnosidase (naringinase) from Penicillium decumbens | Q72254494 | ||
MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 | ||
PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
Structure of Streptomyces Maltosyltransferase GlgE, a Homologue of a Genetically Validated Anti-tuberculosis Target | Q27673803 | ||
Structural Insight into How Streptomyces coelicolor Maltosyl Transferase GlgE Binds α-Maltose 1-Phosphate and Forms a Maltosyl-enzyme Intermediate | Q27682734 | ||
Structural basis for sugar translocation through maltoporin channels at 3.1 A resolution | Q27730332 | ||
Towards automated crystallographic structure refinement with phenix.refine | Q27860678 | ||
Phasercrystallographic software | Q27860930 | ||
Features and development of Coot | Q27861079 | ||
Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing | Q28475117 | ||
Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway | Q28486696 | ||
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces | Q29547258 | ||
Deciphering key features in protein structures with the new ENDscript server | Q29617219 | ||
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation | Q29617258 | ||
Nomenclature for sugar-binding subsites in glycosyl hydrolases | Q29618485 | ||
Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE. | Q33622421 | ||
Does directly observed therapy (DOT) reduce drug resistant tuberculosis? | Q33788435 | ||
Synthesis of a poly-hydroxypyrolidine-based inhibitor of Mycobacterium tuberculosis GlgE | Q34361158 | ||
Stacking interactions between carbohydrate and protein quantified by combination of theoretical and experimental methods | Q34441077 | ||
Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin | Q34527463 | ||
An oxocarbenium-ion intermediate of a ribozyme reaction indicated by kinetic isotope effects | Q34787673 | ||
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection | Q35006626 | ||
Synthesis of 2-deoxy-2,2-difluoro-α-maltosyl fluoride and its X-ray structure in complex with Streptomyces coelicolor GlgEI-V279S. | Q35811933 | ||
Hydrophobicity--shake flasks, protein folding and drug discovery | Q37636267 | ||
Glycosidase inhibition: assessing mimicry of the transition state | Q37672358 | ||
Unexpected and widespread connections between bacterial glycogen and trehalose metabolism | Q37862890 | ||
Transition States, analogues, and drug development | Q38069211 | ||
Bacterial toxin inhibitors based on multivalent scaffolds | Q38069445 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium tuberculosis | Q130971 |
crystal structure | Q895901 | ||
P304 | page(s) | 12830 | |
P577 | publication date | 2015-08-06 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors | |
P478 | volume | 5 |
Q38971223 | Current perspectives on the families of glycoside hydrolases of Mycobacterium tuberculosis: their importance and prospects for assigning function to unknowns |
Q55437850 | Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1): challenging target for antitubercular drug discovery. |
Q38291242 | Ligand-bound Structures and Site-directed Mutagenesis Identify the Acceptor and Secondary Binding Sites of Streptomyces coelicolor Maltosyltransferase GlgE. |
Q36330392 | Structure of Mycobacterium thermoresistibile GlgE defines novel conformational states that contribute to the catalytic mechanism |
Q36629840 | Targeting the trehalose utilization pathways of Mycobacterium tuberculosis |
Q50203520 | Zwitterionic pyrrolidene-phosphonates: inhibitors of the glycoside hydrolase-like phosphorylase Streptomyces coelicolor GlgEI-V279S. |
Search more.